通过与3-氨基-吡咯烷-2,5-二酮-N-芥子气衍生物共同给药增强抗癌药物在小鼠肿瘤中的活性。
Enhanced activity of anticancer drugs in murine tumours by co-administration with 3-amino-pyrrolidine-2,5-dione-N-mustard derivative.
作者信息
Ambaye R Y, Indap M A, Naik S D
机构信息
Cancer Research Institute, Tata Memorial Centre, Bombay, India.
出版信息
J Cancer Res Clin Oncol. 1989;115(4):379-82. doi: 10.1007/BF00400966.
Abstract
(R,S)3-(N,N-[bis-(2-chloroethyl)]-amino)-1-(2'-methoxyphenyl)- pyrrolidine-2,5-dione hydrochloride (I) has shown antitumor activity against P388 and L1210 leukaemias and Sarcoma 180 (ascites). The effect of (I), when co-administered with anticancer drugs, was studied in these murine tumours. Although co-administration of (I) with methotrexate showed a significant increase of the activity against P388 and L1210 leukaemias and Sarcoma 180 (ascites), co-administration of (I) with 5-fluorouracil, mitomycin C, adriamycin or vincristine did not exhibit any enhancing, synergistic or additive effect in the activity of these drugs.
摘要
（R，S）-3-（N，N-二（2-氯乙基）氨基）-1-（2'-甲氧基苯基）吡咯烷-2,5-二酮盐酸盐（I）已显示出对P388和L1210白血病以及肉瘤180（腹水型）具有抗肿瘤活性。在这些小鼠肿瘤中研究了（I）与抗癌药物联合给药时的效果。尽管（I）与甲氨蝶呤联合给药显示出对P388和L1210白血病以及肉瘤180（腹水型）的活性显著增加，但（I）与5-氟尿嘧啶、丝裂霉素C、阿霉素或长春新碱联合给药并未在这些药物的活性中表现出任何增强、协同或相加作用。
相似文献
1
Enhanced activity of anticancer drugs in murine tumours by co-administration with 3-amino-pyrrolidine-2,5-dione-N-mustard derivative.通过与3-氨基-吡咯烷-2,5-二酮-N-芥子气衍生物共同给药增强抗癌药物在小鼠肿瘤中的活性。
J Cancer Res Clin Oncol. 1989;115(4):379-82. doi: 10.1007/BF00400966.
2
Anti-tumour effect of alpha-amino N-substituted-pyrrolidin-2,5-dione-N-mustards on the growth of P388 lymphocytic leukaemia.α-氨基-N-取代-吡咯烷-2,5-二酮-N-氮芥对P388淋巴细胞白血病生长的抗肿瘤作用。
J Cancer Res Clin Oncol. 1987;113(2):151-4. doi: 10.1007/BF00391437.
3
Modulating effect of alpha-[N,N-[bis(2-hydroxyethyl)]-amino-N- (o-methoxyphenyl)-pyrrolidin-2,5-dione on the chemotherapy of murine tumours.α-[N,N-双（2-羟乙基）]氨基-N-（邻甲氧基苯基）-吡咯烷-2,5-二酮对小鼠肿瘤化疗的调节作用
Cancer Lett. 1990 May 30;51(2):119-25. doi: 10.1016/0304-3835(90)90046-z.
4
Anticancer activity of new 3-amino-pyrrolidinedione-nitrogen mustard derivatives on murine sarcoma 180.新型3-氨基-吡咯烷二酮-氮芥衍生物对小鼠肉瘤180的抗癌活性
Anticancer Res. 1987 Jan-Feb;7(1):87-90.
5
Preclinical evaluation of 9-chloro-2-methylellipticinium acetate alone and in combination with conventional anticancer drugs for the treatment of human brain tumor xenografts.单独及与传统抗癌药物联合使用的9-氯-2-甲基玫瑰树碱醋酸盐对人脑肿瘤异种移植瘤治疗的临床前评估。
J Cancer Res Clin Oncol. 1998 Jan;124(1):19-26. doi: 10.1007/s004320050128.
6
Anti-tumor effect of 3-amino-N-substituted-pyrrolidine-2,5-dione-N-mustard hydrochloride.盐酸3-氨基-N-取代吡咯烷-2,5-二酮-N-芥的抗肿瘤作用
Anticancer Drugs. 1991 Jun;2(3):285-8. doi: 10.1097/00001813-199106000-00011.
7
In vitro and in vivo anticancer activity of mitozolomide and sparsomycin in human tumor xenografts, murine tumors and human bone marrow.米托唑胺和稀疏霉素在人肿瘤异种移植、小鼠肿瘤及人骨髓中的体内外抗癌活性
J Cancer Res Clin Oncol. 1990;116(6):550-6. doi: 10.1007/BF01637073.
8
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益：一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
9
Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.基于吉西他滨的晚期胆管癌化疗
Cochrane Database Syst Rev. 2018 Apr 6;4(4):CD011746. doi: 10.1002/14651858.CD011746.pub2.
10
Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer--an open phase II study.5-氟尿嘧啶、口服伊达比星和环磷酰胺联合化疗（FIC）治疗转移性乳腺癌——一项开放性II期研究。
J Cancer Res Clin Oncol. 1988;114(3):301-5. doi: 10.1007/BF00405838.
本文引用的文献
1
Relative sensitivity of the solid and ascites forms of sarcoma 180 and Ehrlich carcinoma to inhibitory compounds.肉瘤180和艾氏癌实体瘤及腹水瘤形式对抑制性化合物的相对敏感性。
Ann N Y Acad Sci. 1958 Dec 5;76(3):575-85. doi: 10.1111/j.1749-6632.1958.tb54876.x.
2
Synergistic and antagonistic interactions of methotrexate and 1-beta-D-arabinofuranosylcytosine in hepatoma cells. The modulating effect of purines.
Biochem Pharmacol. 1981 Feb 1;30(3):223-9. doi: 10.1016/0006-2952(81)90082-4.
3
Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.抗癌药物在小鼠、大鼠、仓鼠、狗、猴和人类中毒性的定量比较。
Cancer Chemother Rep. 1966 May;50(4):219-44.
4
Anticancer activity of new 3-amino-pyrrolidinedione-nitrogen mustard derivatives on murine sarcoma 180.新型3-氨基-吡咯烷二酮-氮芥衍生物对小鼠肉瘤180的抗癌活性
Anticancer Res. 1987 Jan-Feb;7(1):87-90.
5
Anti-tumour effect of alpha-amino N-substituted-pyrrolidin-2,5-dione-N-mustards on the growth of P388 lymphocytic leukaemia.α-氨基-N-取代-吡咯烷-2,5-二酮-N-氮芥对P388淋巴细胞白血病生长的抗肿瘤作用。
J Cancer Res Clin Oncol. 1987;113(2):151-4. doi: 10.1007/BF00391437.
6
Unresolved issues in the biochemical pharmacology of antifolates.抗叶酸剂生化药理学中的未解决问题。
NCI Monogr. 1987(5):9-15.
7
Multiple basis of combination chemotherapy.联合化疗的多种基础
Cancer. 1977 Jul;40(1 Suppl):534-43. doi: 10.1002/1097-0142(197707)40:1+<534::aid-cncr2820400720>3.0.co;2-3.
8
Combination chemotherapy--theory and practice.联合化疗——理论与实践
Semin Oncol. 1977 Jun;4(2):227-53.
9
Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer.联合化疗与单药化疗：癌症药物治疗选择依据的综述
Cancer. 1975 Jan;35(1):98-110. doi: 10.1002/1097-0142(197501)35:1<98::aid-cncr2820350115>3.0.co;2-b.
Zotero 插件